These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7552905)

  • 21. The ethics of leadership in pharmacy.
    Redman BK
    Am J Health Syst Pharm; 1995 Oct; 52(19):2099-104. PubMed ID: 8535944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prescription for improving drug formulary decision making.
    Schiff GD; Galanter WL; Duhig J; Koronkowski MJ; Lodolce AE; Pontikes P; Busker J; Touchette D; Walton S; Lambert BL
    PLoS Med; 2012; 9(5):1-7. PubMed ID: 22629233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug formularies provide a path to best care.
    Curtiss FR
    Am J Health Syst Pharm; 1996 Sep; 53(18):2201-3. PubMed ID: 8879332
    [No Abstract]   [Full Text] [Related]  

  • 24. Lending a drug in short supply.
    Royal MC; Mariano D
    Am J Hosp Pharm; 1994 Apr; 51(8):1025; discussion 1025-9. PubMed ID: 8037221
    [No Abstract]   [Full Text] [Related]  

  • 25. A health priority: continued innovation in pharmaceutical industry and practice.
    McLeod DC
    Drug Intell Clin Pharm; 1979; 13(7-8):447-8. PubMed ID: 10243449
    [No Abstract]   [Full Text] [Related]  

  • 26. Adding an expensive drug to the formulary.
    Uretsky SD; Kaatz BL
    Am J Hosp Pharm; 1993 Aug; 50(8):1667; discussion 1667-71. PubMed ID: 8368221
    [No Abstract]   [Full Text] [Related]  

  • 27. Medication formularies in integrated systems.
    Talley CR
    Am J Health Syst Pharm; 1996 Feb; 53(3):261. PubMed ID: 8808019
    [No Abstract]   [Full Text] [Related]  

  • 28. Medical versus fiscal gatekeeping: navigating professional contingencies at the pharmacy counter.
    Chiarello E
    J Law Med Ethics; 2014; 42(4):518-34. PubMed ID: 25565618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethical decision-making, passivity and pharmacy.
    Cooper RJ; Bissell P; Wingfield J
    J Med Ethics; 2008 Jun; 34(6):441-5. PubMed ID: 18511616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human dignity and pharmaceutical care.
    Lamsam GD
    Am J Health Syst Pharm; 1997 Dec; 54(23):2733-5. PubMed ID: 9408520
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug information: findings from a major study of formularies.
    Rucker TD
    Drug Inf J; 1979; 13(1):41-5. PubMed ID: 10318466
    [No Abstract]   [Full Text] [Related]  

  • 32. Harvey A. K. Whitney lecture. Interdependence in pharmacy: risks, rewards, and responsibilities.
    Zilz DA
    Am J Hosp Pharm; 1990 Aug; 47(8):1759-65. PubMed ID: 2389781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The historical study of an ethics for American pharmacists].
    Kawamura K; Okuda J
    Yakushigaku Zasshi; 1999; 34(1):13-23. PubMed ID: 11623965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Moral dilemmas of pharmacists and the importance of the ethical education].
    Shimodozono Y
    Yakugaku Zasshi; 2009 Jul; 129(7):783-4. PubMed ID: 19571512
    [No Abstract]   [Full Text] [Related]  

  • 35. A practical approach toward teaching ethics to community pharmacists.
    Saw PS; Chuah LH; Lee SWH
    Int J Clin Pharm; 2018 Oct; 40(5):1131-1136. PubMed ID: 30078173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thinking about ethical dilemmas in pharmacy.
    Lowenthal W; Klein WS; Overton CP
    Am J Pharm Educ; 1986; 50(2):161-4. PubMed ID: 10277399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethics in Christianity and health care: can "character" be defined in this interdisciplinary course?
    Broeseker AE
    Ann Pharmacother; 1999 Apr; 33(4):489-94. PubMed ID: 10332541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Writing meeting minutes for a pharmacy and therapeutics committee and its subcommittees.
    Anagnostis E
    Am J Health Syst Pharm; 2015 Jan; 72(2):95-6, 98-9. PubMed ID: 25550131
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of multiattribute utility theory for formulary management in a health system.
    Chung S; Kim S; Kim J; Sohn K
    Am J Health Syst Pharm; 2010 Jan; 67(2):128-35. PubMed ID: 20065267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence at a higher level.
    Ghosh C
    Health Aff (Millwood); 2002; 21(4):298; author reply 298-9. PubMed ID: 12117148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.